CTRI/2017/05/008483尚未招募未知
Oral 5-aminosalicylic Acid Withdrawal in Long Standing inactive Ulcerative Colitis: A Double-blind, Randomized, Placebo-controlled Trial
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- o
- 入组人数
- 194
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. At least 18 years old
- •2. Have a confirmed diagnosis of UC according to established clinical, endoscopic and histologic criteria
- •3. On oral mesalazine or salphasalazine
- •4. in steroid-free clinical remission for at least 1 year
- •5. Stable doses of immunosuppressants for at least 3 months if immunosuppressants are used
- •6. Written informed consent
排除标准
- •Patients are excluded if they have one or more of the following conditions:
- •1. allergic to mesalazine
- •2. Prior bowel surgery except appendectomy
- •3. on anti-TNF therapy
- •4. Concomitant primary sclerosing cholangitis
- •5. Hepatic or renal dysfunction
- •6. Malignant disease within 5 years
- •7. Pregnancy or breast feeding or women of child-bearing age without regular use of contraception
- •8. Terminal illness
研究者
相似试验
已完成
不适用
Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative ColitisColitis, UlcerativeAminosalicylic AcidNCT02537210Chinese University of Hong Kong177
进行中（未招募）
1 期
A randomised trial of aminosalicylate withdrawal in patients with ulcerative colitis in established remission on combination treatment of azathioprine (or 6-mercaptopurine) and an aminosalicylate - CASA trialThe medical condition is Ulcerative Colitis.EUCTR2005-000695-40-GBniversity of Nottingham420
尚未招募
不适用
Persistence of oral 5-ASA treatment in ulcerative colitis.lcerative ColitisJPRN-UMIN000048318MOCHIDA PHARMACEUTICAL CO., LTD.4,400
进行中（未招募）
4 期
Stopping Aminosalicylate Therapy in Inactive Crohn's DiseaseRemissionCrohn DiseaseNCT03261206Alimentiv Inc.334
已完成
不适用
Safety trial of oral coadministration of 5-aminolevulinic acid phosphate and Salacia extractHealthyJPRN-UMIN000038492Hiroshima University50